Literature DB >> 1830274

Neuropathology of the substantia nigra.

W R Gibb1.   

Abstract

Neuronal subpopulations of the substantia nigra pars compacta can be separated into two functionally distinct nigrostriatal projections, the ventral tier which is poorly melanised, and the dorsal tier which is well melanised. In Parkinson's disease, juvenile-onset parkinsonism with dystonia and striatonigral degeneration the ventral tier is more vulnerable than the dorsal tier. The ventral tier mostly projects to the putamen, which is vulnerable in striatonigral degeneration and Huntington's disease. In Huntington's disease spiny neurons of the striatal matrix and neurons of the pars reticulata are particularly susceptible. Determining patterns of selective neuronal death may lead to identification of pathogenetic mechanisms.

Entities:  

Mesh:

Year:  1991        PMID: 1830274     DOI: 10.1159/000116721

Source DB:  PubMed          Journal:  Eur Neurol        ISSN: 0014-3022            Impact factor:   1.710


  16 in total

Review 1.  [Postmortal diagnosis of Parkinson's disease].

Authors:  D Sandmann-Keil; H Braak
Journal:  Pathologe       Date:  2005-05       Impact factor: 1.011

2.  RA Differentiation Enhances Dopaminergic Features, Changes Redox Parameters, and Increases Dopamine Transporter Dependency in 6-Hydroxydopamine-Induced Neurotoxicity in SH-SY5Y Cells.

Authors:  Fernanda M Lopes; Leonardo Lisbôa da Motta; Marco A De Bastiani; Bianca Pfaffenseller; Bianca W Aguiar; Luiz F de Souza; Geancarlo Zanatta; Daiani M Vargas; Patrícia Schönhofen; Giovana F Londero; Liana M de Medeiros; Valder N Freire; Alcir L Dafre; Mauro A A Castro; Richard B Parsons; Fabio Klamt
Journal:  Neurotox Res       Date:  2017-02-02       Impact factor: 3.911

3.  The visual search analogue of latent inhibition: implications for theories of irrelevant stimulus processing in normal and schizophrenic groups.

Authors:  R E Lubow; Oren Kaplan
Journal:  Psychon Bull Rev       Date:  2005-04

4.  Transcriptome analysis reveals link between proteasomal and mitochondrial pathways in Parkinson's disease.

Authors:  D C Duke; L B Moran; M E Kalaitzakis; M Deprez; D T Dexter; R K B Pearce; M B Graeber
Journal:  Neurogenetics       Date:  2006-05-13       Impact factor: 2.660

5.  Differential response of the central noradrenergic nervous system to the loss of locus coeruleus neurons in Parkinson's disease and Alzheimer's disease.

Authors:  Pamela J McMillan; Sylvia S White; Allyn Franklin; J Lynne Greenup; James B Leverenz; Murray A Raskind; Patricia Szot
Journal:  Brain Res       Date:  2010-12-11       Impact factor: 3.252

Review 6.  Mimicking Parkinson's Disease in a Dish: Merits and Pitfalls of the Most Commonly used Dopaminergic In Vitro Models.

Authors:  Fernanda Martins Lopes; Ivi Juliana Bristot; Leonardo Lisbôa da Motta; Richard B Parsons; Fabio Klamt
Journal:  Neuromolecular Med       Date:  2017-07-18       Impact factor: 3.843

7.  Amygdala pathology in Parkinson's disease.

Authors:  H Braak; E Braak; D Yilmazer; R A de Vos; E N Jansen; J Bohl; K Jellinger
Journal:  Acta Neuropathol       Date:  1994       Impact factor: 17.088

Review 8.  The role of dopamine in Huntington's disease.

Authors:  Carlos Cepeda; Kerry P S Murphy; Martin Parent; Michael S Levine
Journal:  Prog Brain Res       Date:  2014       Impact factor: 2.453

9.  Immediate effects of thermal-tactile stimulation on timing of swallow in idiopathic Parkinson's disease.

Authors:  Julie Regan; Margaret Walshe; W Oliver Tobin
Journal:  Dysphagia       Date:  2009-08-26       Impact factor: 3.438

10.  A cross-study transcriptional analysis of Parkinson's disease.

Authors:  Greg T Sutherland; Nicholas A Matigian; Alistair M Chalk; Matthew J Anderson; Peter A Silburn; Alan Mackay-Sim; Christine A Wells; George D Mellick
Journal:  PLoS One       Date:  2009-03-23       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.